Those who observed that a reduction in irisin is associated with an increased risk of hyperglycemia or metabolic syndrome suggest the protective role of irisin against insulin resistance, similar to the relationship observed with adiponectin in metabolic diseases. The gene discussed is FNDC5; the disease is Other metabolic disease.